Short Interest & Thesis

Short Interest & Thesis — Partners Group (PGHN)

Figures converted from Swiss francs at historical FX rates — see data/company.json.fx_rates. Ratios, margins, multiples, percentages, and share counts are unitless and unchanged.

Bottom line. There is no decision-useful reported short-interest, short-sale-volume, or borrow data for Partners Group: Switzerland (SIX) publishes no FINRA-style aggregate short interest and runs no UK/EU-style public net-short disclosure register, and the staged short-interest feed returned zero rows on every channel. The material thesis risk here is not positioning — it is a specific, recent, public short thesis: in late April 2026 short-seller Grizzly Research disclosed a short and published a 37-page report alleging that Partners Group's flagship evergreen funds carry severely mismarked net asset values, estimating up to ~40% of investments may be significantly mis-marked. That claim lands directly on the firm's own disclosed soft spot — performance income that the company itself guides to 25–40% of 2026 revenues [1], and a balance sheet where a "significant portion" of assets is fair-valued using subjective, largely unobservable (Level 3) inputs by management judgment [2]. The company forcefully rejected the report and signalled it was weighing legal action. The strongest evidence is the company's own primary record (which both frames and partly rebuts the thesis); the weakest/missing piece is any quantified short positioning — so this page is a thesis-risk assessment, not a crowding or squeeze read.

Reported positioning — unavailable, and structurally so

Every staged short-interest channel is empty, and that is a market-structure fact, not a data gap to be filled with proxies.

Source: staged short-interest feed (data/short_interest/ — manifest, latest, history, short_sale_volume, public_net_short_disclosures, borrow_pressure, peer_context), all returning zero rows; classification per the feed's own guardrail.

Because there is no shares-short figure and no ADV, days-to-cover and crowding cannot be computed. Per the guardrail in the staged data, daily short-sale volume — even if it existed — would be trading flow, not an outstanding short position, and must never be presented as reported short interest. The honest institutional read: positioning data is not decision-useful for PGHN; the decision-useful question is the credibility of the public short thesis below.

The public short thesis — Grizzly Research (April 2026)

This is the one channel with real, verifiable content. On ~28–29 April 2026, Grizzly Research disclosed a short position in PGHN and published a report alleging widespread valuation overstatement in Partners Group's evergreen (open-ended, semi-liquid) programs. The allegations are summarized below, each separated from the supporting evidence offered, the company's response, and what remains unresolved. These are external short-seller and financial-media sources (staged web research), not the company's filings — treat the allegations as claims, not facts.

Source: external short-seller report (Grizzly Research) and financial media (Bloomberg, Globe and Mail/TipRanks, Opalesque), as staged in data/web-research/forensic-research.json; revenue-mix corroboration from FY2025 Annual Report [1].

A critical structural nuance the headline "40% mismarked" obscures: the alleged mismarking is at the fund / client-NAV level (the USD 184.9bn of AuM), most of which sits off Partners Group's own balance sheet — the firm runs a deliberately balance-sheet-light model [3]. Partners Group's own fair-valued financial investments are roughly $1.4bn. The thesis therefore is not principally a hole in PGHN's balance sheet — it is that fund marks drive PGHN's management and performance fees, its fundraising, and the valuation multiple the market pays. That is why the company's own performance-fee accounting matters.

How the company's own disclosures frame the thesis

The short thesis is not exotic relative to what Partners Group already discloses — the firm itself flags valuation subjectivity and performance-fee reversal risk as critical accounting judgments. The corpus both supports the relevance of the thesis and provides the firm's structured rebuttal.

• Fair value is explicitly judgment-based. For instruments with "little or no observable market inputs" — its private equity, private credit, real estate, infrastructure and royalties holdings — fair value "requires a subjective assessment with varying degrees of judgment" based on "management's judgment" [2]. This is the disclosure the short thesis is built on.
• Performance fees carry an explicit reversal/claw-back constraint. Partners Group recognizes performance fees only with a "sufficiently large cushion," applying a quarterly Write-Down Test with a 50% discount (up to 100% for selected programs), reviewed by the Board, and reverses recognized fees when no-reversal is no longer highly probable [4]. This is the firm's structural answer to "marks feed revenue": conservatism is built into recognition.
• The auditor flags exactly these areas as key audit matters. PwC identifies "Recognition of revenues from management services, net" and "Valuation of financial investments and assets held for sale" as the two key audit matters, with overall group materiality of $58 million (benchmark: profit before tax); full/specific-scope work covered 80% of Group revenue and 74% of total assets [5]. An unqualified opinion on these areas is a meaningful (though not dispositive) counterweight to a mismarking allegation.
• Performance income is genuinely material and rising. Performance fees were $1,033m, 32% of 2025 revenue (up from 24% in 2024), and the company guides performance income to 25–40% of 2026 revenues [1]; net performance fees of $1,032.8m are reported in the audited accounts [6]. The short thesis is correct that this line is large and mark-sensitive; it is disputed on whether the marks are wrong.

Source: FY2025 Annual Report, 2025 at a glance — Financials [1].

Performance fees (red) — the most mark-sensitive line and the focus of the short thesis — jumped from 24% to 32% of revenue in a single year, which is exactly why a credible mismarking claim would be material to the equity.

Ownership, float and liquidity — the squeeze/de-risking context

With no shares-short figure, crowding cannot be quantified — but the share register tells you who would be on the other side of any short and how tradable the float is.

Source: FY2025 Annual Report — Key Figures (free float, total shares) [7]; Significant shareholders and treasury (916,865 shares = 3.43%) [8].

Source: FY2025 Annual Report — Shareholders above 5% (statutory note 13) [9]; Corporate Governance — Significant shareholders [8].

Free float is high at 84.87% [7], so the stock is genuinely tradable and a short would not face an obvious lendable-supply wall — but the three founders still hold ~15% combined under a shareholders' agreement (Gantner as representative) [9], and the firm holds 916,865 treasury shares (3.43%) [8]. That is a stable, aligned core that resists forced selling — relevant to a short only as a reason the thesis would need to win on fundamentals (marks/redemptions), not on a liquidity break. Capital structure adds little stress to a short or long case: conditional capital is reserved for incentive plans and a 2024 capital band caps any issuance at ~10% with no capital reductions allowed [10]; the $3.5bn-equivalent (EUR 3,000m) syndicated facility is unsecured and not subject to covenants [11], and available liquidity was $4,694m on a balance-sheet-light model [3].

Market setup — the tape reaction to the report

The only positioning-adjacent signal available is the price reaction to the report. The stock had already been weakening into late April 2026 and fell ~4% on the report day (28→29 April), down roughly 10% peak-to-trough across the week, before recovering most of the move within two weeks.

Source: daily price series, as staged (data/prices/daily.json); price/volume signal, not short-interest data.

The partial, fairly quick recovery toward ~$1,092 says the market priced some risk but did not capitulate to the thesis — consistent with an unresolved, contested allegation rather than a confirmed fraud. For a PM, the setup is asymmetric in a specific way: the near-term catalyst path (H1 2026 results on 1 September 2026, AuM update 15 July 2026) is now read through a "are the marks/redemptions holding?" lens, and any sign of accelerating evergreen redemptions or a performance-fee reversal would re-energize the short, while a clean audit cycle and continued fundraising would bleed it out.

Evidence quality

Source: classification derived from the staged short-interest feed (data/short_interest/), staged web research (data/web-research/), and the FY2025 Annual Report key audit matters [5].

Net judgment for a PM. Ignore "short interest" as a factor — it is unmeasurable here. Do not treat the Grizzly report as proven; treat it as a credible, specific, and so-far-unrefuted thesis-risk flag on the most mark-sensitive, fastest-growing part of the P&L. The disconfirming/confirming evidence to watch is concrete and dated: the 15 July 2026 AuM update and 1 September 2026 H1 results (evergreen flows, redemption gating, any performance-fee reversal), the firm's promised rebuttal/legal follow-through, and whether the FY2026 audit re-affirms the valuation and revenue-recognition key audit matters without qualification.